Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide

Table 1

		Number (%) or Median(mean ±SD)
Variables	Total	NLR < 2.14	NLR≧2.14	p value
Number	106	35(33%)	71(67%)
Age (years)		74 (72.0±1.56)	73 (72.4±0.84)	0.77
Gleason Sum
<9	46(43.4%)	15(42.8%)	31(43.7%)	1.00
≧9	51(48.1%)	17(48.6)	34(47.9%)
Unknown	9(8.5%)	3(8.6%)	6(8.4%)
Metastasis	73(68.8%)	22(62.8%)	51(71.8%)	0.598
Visceral metastases	9(8.8%)	4(11.4%)	5(7.0%)	0.474
Performance status
0	51	17	34	0.611
1	12	4	8
2	2	1	1
3	0	0	0
4	1	1	0
Unknown	40	12	28
Pre docetaxel	38	9	29	0.139